Diagnostic and Biotech

Diagnostics are not exclusively used for the treatment of diseases but also for prediction of diseases. Additionally, it is also used for clinical development of drugs, identify reactions of particular diagnostics to patients, and improving outcomes of patients. Big Market Research reports on diagnostic and biotech industry assists businesses to gain thorough understanding of current and future market status. Additionally, it furnishes an extensive analysis of factors driving and restraining growth of the industry along with opportunities, detailed segmentation, and development trends of the market. Moreover, recent news, standards & regulations, policies, and new findings in the industry are cited. Comprehensive market statistics have been highlighted in the report to aid investors and stakeholders to implement various strategies to consolidate their position and sustain in the market.

No of Reports 5847

Glutamine Market by Application (Biotechnology, Personal Care & Cosmetics, Pharmaceuticals) and by Region, Trend, Forecast, Competitive Analysis, and Growth Opportunity 2019-2024

The analysts forecast the global glutamine market to exhibit a CAGR of 5.42% during the period 2019-2024. The report covers the present scenario and the growth prospects of the global glutamine for 2019-2024. To calculate the market size, the report considers the glutamine sales volume and revenue. The projections featured in the report have been derived using proven research methodologies and as...

  • Publish Date: July 27, 2019
  • $3000
Prenatal and Newborn Genetic Testing Market to 2027 - Global Analysis and Forecasts By Product (Diagnostic, and Screening), Disease (Cystic Fibrosis, Sickle Cell Anemia, Downs Syndrome, Phenylketonuria, and Other Disease), End User (Hospitals and Clinics, Diagnostic Centers, and Other End User) and Geography

The global Prenatal and Newborn Genetic Testing Market is expected to reach US$ 11,204.74 Mn in 2027 from US$ 4,034.37 in 2018. The market is estimated to grow with a CAGR of 12.2% from 2019-2027. The key factors that are driving the growth of the significant increase in the prevalence of genetic diseases among infants, supportive government for promoting the use of prenatal and newborn testing an...

  • Publish Date: July 12, 2019
  • $4550
World Plant Growth Chamber Market by Product Type, market, Players and Regions-Forecast to 2024

Summary ICRWorld’s Plant Growth Chamber market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The report includes the forecas...

  • Publish Date: July 24, 2019
  • $2960
Asia Pacific Next Generation Sequencing Market to 2027- Regional Analysis and Forecasts By Product (Platforms, Services, Consumables); Service (Genome Sequencing, Exome Sequencing, Resequencing Targeted Sequencing, & Other Sequencing Technologies); Application (Diagnostics, Drug Discovery, Precision Medicine, & Other Applications); & End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals Clinics, & Other End Users), and Country

The Asia Pacific next generation sequencing market is expected to reach US$ 5,835.6 Mn in 2025 from US$ 1,203.6 Mn in 2017. The market is estimated to grow with a CAGR of 21.8% from 2018-2025. Driving factor such as price reduction in sequencing technology and technological developments in next generation sequencing are likely to promote market growth. Whereas, the restricted threat of genetic and...

  • Publish Date: June 28, 2019
  • $3000
Europe Next Generation Sequencing Market to 2025 - Regional Analysis and Forecasts by Product (Platforms, Services, Consumables); Service (Genome Sequencing, Exome Sequencing, Resequencing Targeted Sequencing, & Other Sequencing Technologies); Application (Diagnostics, Drug Discovery, Precision Medicine, & Other Applications); & End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals Clinics, & Other End Users), and Country

The Europe next generation sequencing market is expected to reach US$ 7,685.4 Mn in 2025 from US$ 1,633.4 Mn in 2017. The market is estimated to grow with a CAGR of 21.4% from 2018-2025. The growth of the next generation sequencing market is primarily attributed to the technological advancements in sequencing and an extensive use of genomics for medical applications. However, nonexistence of skill...

  • Publish Date: June 14, 2019
  • $3000
North America Next Generation Sequencing Market to 2025 - Regional Analysis and Forecasts by Product (Platforms, Services, Consumables); Service (Genome Sequencing, Exome Sequencing, Resequencing Targeted Sequencing, & Other Sequencing Technologies); Application (Diagnostics, Drug Discovery, Precision Medicine, & Other Applications); & End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals Clinics, & Other End Users), and Country

The North America next generation sequencing market is expected to reach US$ 10,733.0 Mn in 2025 from US$ 2,378.5 Mn in 2017. The market is estimated to grow with a CAGR of 20.7% from 2018-2025. The growth of the next generation sequencing market is primarily attributed to the declining price of sequencing and increasing prevalence of cancer. However, risks associated with genetic data and high co...

  • Publish Date: May 15, 2019
  • $3000
Contrast Media Agents Market to 2027- Global Analysis and Forecasts By Type (Iodinated Contrast Media, Gadolinium Based Contrast Media, Barium-Based Contrast Media, Microbubble Contrast Media); Imaging Modality (X-Ray/CT, Magnetic Resonance Imaging, Ultrasound); Indication (Cardiovascular Disorders, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, Nephrological Disorders); Route of Administration (Intravascular, Oral, Rectal), and Geography

The global contrast media agents market is expected to reach US$ 6,860.6 Mn in 2027 from US$ 4,855.2 Mn in 2018. The contrast media agents market is estimated to grow with a CAGR of 4.0% from 2019-2027. The market is driven by the factors such as, increasing prevalence of chronic diseases, development in diagnostic imaging modalities coupled with rising numbers of diagnostic test procedures and in...

  • Publish Date: May 31, 2019
  • $4550
North America Next Generation Sequencing Market to 2025 - Regional Analysis and Forecasts by Product (Platforms, Services, Consumables); Service (Genome Sequencing, Exome Sequencing, Resequencing Targeted Sequencing, & Other Sequencing Technologies); Application (Diagnostics, Drug Discovery, Precision Medicine, & Other Applications); & End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals Clinics, & Other End Users), and Country

The North America next generation sequencing market is expected to reach US$ 10,733.0 Mn in 2025 from US$ 2,378.5 Mn in 2017. The market is estimated to grow with a CAGR of 20.7% from 2018-2025. The growth of the next generation sequencing market is primarily attributed to the declining price of sequencing and increasing prevalence of cancer. However, risks associated with genetic data and high co...

  • Publish Date: May 15, 2019
  • $3000
Asia Pacific Genomics Market to 2025 - Regional Analysis and Forecasts by Technology (Sequencing, Microarray, PCR, Nucleic Acid Extraction and Purification and Others), Product & Service (Instruments/Systems, Consumables and Services), Application (Diagnostics, Drug Discovery and Development, Precision/Personalized Medicine, Agriculture & Animal Research and Others) End User (Research Centers, Hospitals and Clinics, Pharmaceutical & Biotechnology Companies and Others) and Country

The Asia Pacific genomics market is expected to reach US$ 7.6 Bn in 2025 from US$ 3.2 Bn in 2017. The market is estimated to grow with a CAGR of 10.6% from 2018-2025. The growth of the genomics market is primarily attributed to the increasing number of start-up companies and medical genetics in developing countries. However, nonexistence of skilled professionals and perception of the people for ge...

  • Publish Date: April 30, 2019
  • $3000
Europe Genomics Market to 2025 - Regional Analysis and Forecasts by Technology (Sequencing, Microarray, PCR, Nucleic Acid Extraction and Purification and Others), Product & Service (Instruments/Systems, Consumables and Services), Application (Diagnostics, Drug Discovery and Development, Precision/Personalized Medicine, Agriculture & Animal Research and Others) End User (Research Centers, Hospitals and Clinics, Pharmaceutical & Biotechnology Companies and Others) and Country

The Europe genomics market is expected to reach US$ 10.1 Bn in 2025 from US$ 4.6 Bn in 2017. The market is estimated to grow with a CAGR of 10.6% from 2018-2025. The growth of the genomics market is primarily attributed to the rise in the advancements for genome editing technologies and technological developments in genomics. However, nonexistence of skilled professionals and risks associated with...

  • Publish Date: April 30, 2019
  • $3000
North America Genomics Market to 2025 - Regional Analysis and Forecasts by Technology (Sequencing, Microarray, PCR, Nucleic Acid Extraction and Purification and Others), Product & Service (Instruments/Systems, Consumables and Services), Application (Diagnostics, Drug Discovery and Development, Precision/Personalized Medicine, Agriculture & Animal Research and Others), End User (Research Centers, Hospitals and Clinics, Pharmaceutical & Biotechnology Companies and Others) and Country

The North America genomics market is expected to reach US$ 13.3 Bn in 2025 from US$ 5.9 Bn in 2017. The market is estimated to grow with a CAGR of 11.0% from 2018-2025. The growth of the genomics market is primarily attributed to the growth in investments & funds for genomics and declining cost of sequencing procedures. However, t high cost of equipment used in genomics and limitations in genomics...

  • Publish Date: April 30, 2019
  • $3000
Asia Pacific Genome Editing Market to 2025 - Regional Analysis and Forecasts by Technology (TALENS, CRISPR, Zinc Finger Nucleases (ZFNs), Antisense RNA and Others), Application (Genetic Engineering, Cell Line Engineering and Others) End User (Biotechnology & Pharmaceutical Companies, Contract Research Organizations (CROs), and Academic & Government Research Institutes), and Country

The Europe genome editing market is expected to reach US$ 3,421.1 Mn in 2025 from US$ 1,052.9 Mn in 2017. The market is estimated to grow with a CAGR of 16.7% from 2018-2025. The growth of the genome editing market is primarily attributed to the rise in the advancements for genome editing technologies and technological developments in genomics. However, European Court of Justice ruling on genome e...

  • Publish Date: April 15, 2019
  • $3000
Europe Genome Editing Market to 2025 - Regional Analysis and Forecasts by Technology (TALENS, CRISPR, Zinc Finger Nucleases (ZFNs), Antisense RNA and Others), Application (Genetic Engineering, Cell Line Engineering and Others) End User (Biotechnology & Pharmaceutical Companies, Contract Research Organizations (CROs), and Academic & Government Research Institutes), and Country

The Europe genome editing market is expected to reach US$ 3,421.1 Mn in 2025 from US$ 1,052.9 Mn in 2017. The market is estimated to grow with a CAGR of 16.7% from 2018-2025. The growth of the genome editing market is primarily attributed to the rise in the advancements for genome editing technologies and technological developments in genomics. However, European Court of Justice ruling on genome e...

  • Publish Date: April 15, 2019
  • $3000
North America Genome Editing Market to 2025 - Regional Analysis and Forecasts by Technology (TALENS, CRISPR, Zinc Finger Nucleases (ZFNs), Antisense RNA and Others), Application (Genetic Engineering, Cell Line Engineering and Others) End User (Biotechnology & Pharmaceutical Companies, Contract Research Organizations (CROs), and Academic & Government Research Institutes), and Country

The North America genome editing market is expected to reach US$ 4,148.1 Mn in 2025 from US$ 1,234.5 Mn in 2017. The market is estimated to grow with a CAGR of 17.2% from 2018-2025. The growth of the genome editing market is primarily attributed to the rise in the production of genetically modified crops and rising prevalence of the genetic diseases. However, the stringent regulatory framework and...

  • Publish Date: April 15, 2019
  • $3000
Oligonucleotide Synthesis Market to 2027- Global Analysis and Forecasts By Product (Synthesized Oligonucleotides, Reagents, and Equipment), Application (Research, Diagnostics, and Therapeutics), End User (Academic Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Other End Users), and Geography

The global oligonucleotide synthesis market is expected to reach US$ 3,971.72 Mn in 2027 from US$ 1,584.16 Mn in 2018. The market is estimated to grow with a CAGR of 11.1% from 2019-2027. The growth of the oligonucleotide synthesis market is primarily attributed to the increasing applications of synthesized oligonucleotides, increasing investments for synthetic biology, technological advancements ...

  • Publish Date: March 15, 2019
  • $4550
Healthcare CMO Market to 2027- Global Analysis and Forecasts by Service (Pharmaceutical Contract Manufacturing Services and Medical Device Contract Manufacturing Services); and Geography

The global healthcare CMO market is expected to reach US$ 223,355.6 Mn in 2027 from US$ 80,479.4 in 2018. The healthcare CMO market is estimated to grow with a CAGR of 12.2% from 2019-2027. The market is driven by the factors such as, increasing inclination of pharmaceutical and medical device manufacturers towards outsourcing, increasing patent cliffs and rising geriatric population coupled with...

  • Publish Date: March 8, 2019
  • $4550
Narcolepsy Market to 2027- Global Analysis and Forecasts by Type (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, and Secondary Narcolepsy); Product (Central Nervous System (CNS) Stimulants, Sodium Oxybate, and Antidepressants); Distribution Channel (Hospital Pharmacies and Retail Pharmacies) and Geography

The global narcolepsy market is expected to reach US$ 4,537.9 Mn in 2027 from US$ 2,026.8 Mn in 2018. The market is estimated to grow with a CAGR of 9.5% from 2019-2027. The growth of the narcolepsy market is primarily attributed to the rising prevalence of sleep related neurological disorders, emerging local pharmaceutical and biopharmaceutical companies, and increasing awareness regarding neurol...

  • Publish Date: February 28, 2019
  • $4550
North America Metagenomics Market to 2027- Regional Analysis and Forecasts by Product (Instruments & Software and Consumables), Application (Clinical Diagnostics, Drug Discovery Metagenomics and Others) and Country

The North America Metagenomics market is expected to reach US$ 106.9 Mn in 2027 from US$ 55.2 Mn in 2018. The market is estimated to grow with a CAGR of 8.0% from 2018-2027. The growth of the market is driven by the factors such as increasing investments in the metagenomics and diverse applications of metagenomics, in the North America region. Whereas, high cost associated with metagenomics is lik...

  • Publish Date: February 27, 2019
  • $3000
Europe Metagenomics Market to 2027 - Regional Analysis and Forecasts by Product (Instruments & Software and Consumables), Application (Clinical Diagnostics, Drug Discovery Metagenomics and Others) and Country

The Europe Metagenomics market is expected to reach US$ 89.7 Mn in 2027 from US$ 48.6 Mn in 2018. The market is estimated to grow with a CAGR of 7.4% from 2018-2027. The growth of the market is driven by the factors such as technological advancements in the metagenomics, growing preference for Metagenomics over traditional methods and wide range metagenomics applications, in the Europe region. Whe...

  • Publish Date: February 27, 2019
  • $3000
Asia Pacific Metagenomics Market to 2027 - Regional Analysis and Forecasts by Product (Instruments & Software and Consumables), Application (Clinical Diagnostics, Drug Discovery Metagenomics and Others) and Country

The Asia pacific Metagenomics market is expected to reach US$ 61.9 Mn in 2027 from US$ 30.6 Mn in 2018. The market is estimated to grow with a CAGR of 8.5% from 2018-2027. The growth of the market is driven by the factors such as increasing demand for genomics, growing demand for metagenomics over traditional methods and various applications of metagenomics, in the Asia pacific region. Whereas, ex...

  • Publish Date: February 27, 2019
  • $3000
North America Human Microbiome Market to 2025 - Regional Analysis and Forecasts by Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs, and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others), Application (Therapeutics and Diagnostics), and Country

The North America human microbiome market is expected to reach US$ 446.39 Mn in 2025 from US$ 113.88 in 2017. The market is estimated to grow with a CAGR of 21.5% from 2018-2025. The growth of the market is driven by the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies and growing technological advancements in human microbiome and next-gene...

  • Publish Date: February 27, 2019
  • $3000
Europe Human Microbiome Market to 2025 - Regional Analysis and Forecasts by Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs, and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others), Application (Therapeutics and Diagnostics), and Country

The Europe human microbiome market is expected to reach US$ 346.67 Mn in 2025 from US$ 72.34 in 2017. The market is estimated to grow with a CAGR of 22.2% from 2018-2025. The growth of the market is driven by the factors such alarming rise in non-communicable diseases (NCDS), rising efforts in the development of human microbiome based therapies and developments in genomics and sequencing technique...

  • Publish Date: February 27, 2019
  • $3000
Asia Pacific Human Microbiome Market to 2025 - Regional Analysis and Forecasts by Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs, and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others), Application (Therapeutics and Diagnostics), and Country

The Asia Pacific human microbiome market is expected to reach US$ 207.81 Mn in 2025 from US$ 41.73 in 2017. The market is estimated to grow with a CAGR of 22.8% from 2018-2025. The growth of the market is driven by the factors such as rising chronic disease due to change in lifestyle and growing interest in human microbiome treatment approach. Whereas, stringent regulatory environment and lack of ...

  • Publish Date: February 27, 2019
  • $3000
Bioreactors Market to 2027- Global Analysis and Forecasts by Product Class (Benchtop (Up To15l), Pilot Scale (15 - 1000L) and Industrial Scale (>1000L)); Application (Microbial Application and Cell Culture); Process (Bio production, Research & Development, and Process Development) and Geography

The global bioreactors market is expected to reach US$ 4,811.5 Mn in 2027 from US$ 2,850.2 Mn in 2018. The market is estimated to grow with a CAGR of 6.3% from 2019-2027. The growth of the bioreactors market is primarily attributed to the increasing investments in R&D and other activities. Moreover, the rapid growth of pharmaceutical and biotechnology industry is also expected to drive the growth ...

  • Publish Date: February 18, 2019
  • $4550
Metagenomics Market to 2027 - Global Analysis and Forecasts by Product (Instruments & Software and Consumables), Application (Clinical Diagnostics, Drug Discovery Metagenomics and Others) and Geography

The global metagenomics market is expected to reach US$ 314.3 Mn in 2027 from US$ 165.8 in 2018. The market is estimated to grow with a CAGR of 7.7% from 2018-2027. Driving factors such as increasing venture capital investments, advantages of metagenomics in biotechnology and industrial applications of metagenomics. Whereas, the trend of the extensive set of molecular-based approaches positive imp...

  • Publish Date: January 28, 2019
  • $4550
Human Microbiome Market to 2025 - Global Analysis and Forecasts by Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs, and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others), Application (Therapeutics and Diagnostics), and Geography

The global human microbiome market is expected to reach US$ 1,197.08 Mn in 2025 from US$ 257.30 Mn in 2017. The market is estimated to grow with a CAGR of 21.8% from 2018-2025. The increasing incidence of lifestyle diseases are expected to fuel the market growth during the forecast period. As per World health organization in 2016, 13% of the world population (adults) were obese. According to the "...

  • Publish Date: January 28, 2019
  • $4550
DNA Next Generation Sequencing Market to 2025 - Global Analysis and Forecasts By Product (Platforms, Services and Consumables); Application (Diagnostics, Drug Discovery, Precision Medicine, & Other Applications); & End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals Clinics, & Other End Users) and Geography

The global DNA next generation sequencing market is expected to reach US$ 22,716.9 Mn in 2025 from US$ 4,898.5 Mn in 2017. The market is estimated to grow with a CAGR of 21.7% from 2018-2025. The growth of the DNA next generation sequencing market is attributed to the declining prices of sequencing services as well as various technological advancements in the field of sequencing during the recent ...

  • Publish Date: January 21, 2019
  • $4550
NGS-Based RNA-Seq Market to 2027 - Global Analysis and Forecasts By Product & Services (Sample Preparation, Sequencing Services, Sequencing Platform & Consumables and Data Analysis, Storage & Management), Technology (Sequencing by Synthesis, Nanopore Sequencing, Ion Semiconductor Sequencing and Single Molecule Real Time Sequencing), Application (Diagnostics, Drug Discovery, Precision Medicine and Others), End User (Biotechnology & Pharmaceutical Companies, Hospitals & Clinics, Research Centers and Academic & Government Institutes and Others ) and Geography

In the report the NGS based RNA seq market, the market is expected to reach US$ 7,984.90 Mn in 2027 from US$ 1,414.59 in 2018. The market is estimated to grow with a CAGR of 19.3% from 2018-2027. The NGS based RNA seq market is driven by the driving factor such as reduced cost of genome sequencing, advancements in sequencing technology and next generation sequencing for cancer However, the market...

  • Publish Date: January 2, 2019
  • $4550
Epigenetics Market to 2025 - Global Analysis and Forecasts by Product (Reagents, Kits, Enzymes, Instruments & Consumables and Bioinformatics Tools), Technology (Histone Modification, DNA Methylation and Others), Application (Oncology, Cardiovascular Diseases and Others) End Users (Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organization) and Geography

In the report the epigenetics market, the market is expected to reach US$ 2,611.57 Mn in 2025 from US$ 991.45 in 2017. The market is estimated to grow with a CAGR of 13.6% from 2017-2025. The epigenetics market is driven by the driving factor such as declining prices of sequencing, and is likely to drive the market in the coming years. The declining costs associated with different strategies and ...

  • Publish Date: January 2, 2019
  • $4550
dPCR and qPCR Market to 2025 - Global Analysis and Forecasts by Technology (Digital PCR (dPCR) and Quantitative PCR (qPCR)); Product (Reagents & Consumables, Instruments, and Software and Services); Application (Clinical Application, Research Application, and Forensic Application) and Geography

In the report the dPCR and qPCR market, the market is expected to reach US$ 6,371.6 Mn in 2025 from US$ 3,255.5 in 2017. The market is estimated to grow with a CAGR of 9.1% from 2017-2025. The dPCR and qPCR market is driven by the driving factor such as increasing incidence of genetic diseases, growth in investments & funds for dPCR and qPCR techniques and gene synthesis, increasing number of sta...

  • Publish Date: November 26, 2018
  • $4550